DR. ZUBOWSKI COUNSELS THAT LONGER EYELASHES ARE ALWAYS DESIRABLE

I’ve wanted to mention this subject ever since I wrote my first blog: it’s ironic, but men possess an advantage over women with respect to eyelashes: typically they have long, thick lashes, the very attribute considered to be an emblem of beauty in women.

For centuries having long, thick, dark lashes have been a quality that most women desire. False eyelashes plus the right makeup can, to some extent, mimic long natural lashes and make the eyes appear wider and more attractive.

At the Robert Zubowski MD Center for Plastic and Reconstructive Surgery in Paramus, NJ, we can offer another option that, I believe, offers you the most natural, if temporary, results. You may have already heard of Latisse®. It is the only FDA-approved product for individuals with hypotrichosis (sparse eyelashes). It is a prescription product that you yourself apply at home to the skin at the margins of your upper eyelids every evening for 16 to 20 weeks to achieve long, thick, dark lashes. Optimum results are typically seen in about two months. Once you stop your treatment your lashes will revert to their former state over the next several weeks or for some, even months.

Some patients begin a course of Latisse because of an upcoming event where they want to look their best. I can’t stress too emphatically that it is important to obtain your Latisse prescription from a specialist in cosmetic rejuvenation. You can rely on my 25 years of experience as a board certified plastic surgeon to educate you not only of the advantages but of the possible risks or limitations of your procedure so that you can proceed with your “eyes wide open.”

If you’d like more information about Latisse or are considering other cosmetic rejuvenation procedures please contact our office manager who will set up your consultation. Meanwhile, you might like to further familiarize yourself with Latisse by going to www.latisse.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

Any Questions?

Latest News